News & Events
Proceeds from the award will be used to advance novel “Smart Growth Factors” toward clinical development San Francisco, Calif. – […]
Posted on May 5, 2015
Matt Onsum and Saroja Ramanujan (Genentech) will be co-chairing a session on Quantitative Systems Pharmacology in Cardiovascular Disease at the 5th […]
Posted on September 17, 2014
The need for better therapies
Coronary heart disease is the single biggest killer in the United States, yet current therapy are unable to significantly protect or regenerate the damaged heart tissue following a heart attack
are caused by hear disease. Heart disease is the number 1 leading cause of death in the US.
About half the US population has one of the primary risk factors for heart.
Current therapies only manage the symptoms of heart disease. Our goal is create therapies that enhance the body's healing response and repair damaged tissue
- Board of Directors
- Scientific Advisory Board
President and CEOFull Bio